Balaxi Pharma Ltd
NSE: BALAXI · Other · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹15 cr vs borrowings ₹56 cr (FY26): borrowings are higher by ₹41 cr.
- Borrowings rose in each of the last 3 years (₹12 cr → ₹56 cr).
- Operating profit covered interest 2.8x in the last 12 months.
- Operating cash flow was below net profit in 4 of the last 5 years (FY26, FY25, FY23, FY22).
- Revenue was higher than a year earlier in 1 of the last 4 quarters.
- Other income was 149% of net profit in the last 12 months.
- Debtor days went from 84 (FY24) to 184 (FY26).
- Dividend paid in 1 of the last 5 financial years.
- Price ₹19.70 on 2026-10-26: -55.1% from the 52-week high, +29.6% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 77 | 73 | 76 | 71 | 56 | 73 | 71 | 81 |
| EBITDA | 11 | 4 | 13 | 4 | 1 | 3 | 0 | 5 |
| OPM % | 13.7% | 5.4% | 16.5% | 5.9% | 2.1% | 4.3% | 0.2% | 5.8% |
| Other income | -4 | 4 | -2 | -2 | 2 | 0 | 3 | -1 |
| Net profit | 5 | 5 | 9 | 0 | 0 | 0 | 1 | 1 |
| EPS (₹) | 0.84 | 0.97 | 1.56 | 0.05 | 0.04 | 0.06 | 0.11 | 0.24 |
| Revenue YoY | -27.4% | -1.0% | -7.3% | +14.1% | ||||
| Profit YoY | -95.4% | -94.4% | -92.9% | +348.3% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 279 | 336 | 241 | 293 | 270 | 280 |
| EBITDA | 50 | 57 | 8 | 37 | 9 | 9 |
| Net profit | 48 | 46 | -2 | 25 | 1 | 2 |
| EPS (₹) | 9.53 | 9.16 | -0.46 | 4.54 | 0.26 | 0.45 |
| Revenue growth | +20.4% | -28.3% | +21.2% | -7.7% | -5.9% | |
| Profit growth | -3.6% | -105.2% | – | -94.3% | -87.2% | |
| Dividend / share (₹) | – | 0.50 | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | -7.1% | +3.2% | -5.9% |
| Net profit | -68.6% | -48.0% | -87.2% |
| EPS | -69.5% | -49.1% | – |
| Share price | – | -52.2% (2y) | -50.2% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 183 | 201 | 232 | 249 |
| Borrowings | – | 12 | 18 | 52 | 56 |
| Cash & equivalents | – | 28 | 62 | 39 | 15 |
| Total assets | – | 240 | 258 | 310 | 337 |
| Fixed assets | – | 16 | 15 | 14 | 49 |
| Capital work in progress | – | 3 | 2 | 22 | – |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 53 | 56 | 111 | 136 |
| Inventory | – | 105 | 82 | 78 | 83 |
| Payables | – | 36 | 29 | 16 | 21 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 34 | 6 | 5 | -35 | -4 |
| Cash from investing | -28 | -11 | -1 | -22 | -21 |
| Cash from financing | -0 | 26 | 30 | 34 | 0 |
| Capex | 5 | 11 | 1 | 1 | 15 |
| Free cash flow | 29 | -5 | 4 | -36 | -19 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 25.1% | -1.2% | 10.8% | 0.6% |
| ROCE % | – | 29.5% | 1.7% | 11.2% | 3.0% |
| Debtor days | – | 58 | 84 | 138 | 184 |
| Inventory days | – | 189 | 233 | 173 | 202 |
| Payable days | – | 66 | 82 | 36 | 51 |
| Cash conversion cycle (days) | – | 181 | 235 | 275 | 335 |
| Working capital days | – | 152 | 236 | 235 | 256 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 65.99% |
| FIIs | 0.00% |
| DIIs | 2.56% |
| Public (non-institutions) | 31.45% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% |
| Promoter group | % |
|---|---|
| Balaxi Overseas Private Limited | 63.40% |
| Ashish Maheshwari | 1.64% |
| Minoshi Maheshwari | 0.96% |
| Public holders above 1% | % |
|---|---|
| RGSL Investment Fund - RGSL Investment LVF 1 | 2.54% |
| Kunal Mahendra Bhakta | 1.86% |
| Amol Anand Mantri | 1.41% |
| P P Zibi Jose | 1.29% |
14,474 shareholders. Pledged: – of promoter shares.
Peers in Other
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| TSFINV | ₹8,585 cr | 17.6x | 1.4x | 8.4% | 3.6% | 20.5% | +121.7% | 2.30% |
| KRISHANA | ₹6,339 cr | 39.9x | 11.3x | 41.6% | 23.2% | 12.6% | +95.7% | 0.05% |
| MARINE | ₹5,431 cr | 84.2x | 11.0x | 14.3% | 18.0% | 10.8% | +25.6% | 0.07% |
| ZOTA | ₹4,139 cr | – | 6.0x | -22.5% | -12.4% | -0.5% | +56.7% | 0.07% |
| AIMTRON | ₹3,319 cr | 71.7x | 17.1x | 28.0% | 31.8% | 21.8% | – | – |
| ACCORD | ₹2,984 cr | – | 261.7x | 12.4% | 12.0% | 2.4% | – | – |
| MONOLITH | ₹2,646 cr | 64.6x | 24.3x | 36.0% | 48.7% | 24.4% | – | – |
| UTSSAV | ₹2,390 cr | 40.2x | 14.1x | 43.4% | 54.7% | 7.9% | – | – |
| BETA | ₹2,200 cr | 40.6x | 5.0x | 16.4% | 17.0% | 20.8% | – | – |
| BALAXI | ₹109 cr | 43.8x | 0.4x | 1.0% | 3.3% | 3.2% | -7.0% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2024-05-30 | Split | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share |
| 2022-07-01 | Dividend | Annual General Meeting/Dividend - Rs 0.50 Per Share |
| 2017-09-21 | Other | Annual General Meeting |
| 2016-09-22 | Other | Annual General Meeting |
Documents
- Annual report FY26
- Annual report FY26
- Annual report FY25
- Annual report FY25
- Annual report FY24
- Announcements NSE filings
- Latest results (data file) XBRL
Links go to the original files on the exchange website.
About the company
| Sector | |
| Industry | Other |
| Sub-industry | |
| Symbol | BALAXI |
| BSE code | – |
| ISIN | INE618N01022 |
| Face value | ₹2.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.